This inventor holds 1 USPTO granted patent. Top assignee: Thera Patent Gmbh & Co. Kg. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Innovations by Peter Reitz in Implantable Active Substance Depot Materials
Introduction
Peter Reitz is an accomplished inventor based in Obertshausen, Germany. He has made significant contributions to the field of medical technology, particularly in the development of implantable active substance depot materials. His innovative work focuses on enhancing the delivery of chemotherapeutic agents through advanced materials.
Latest Patents
Peter Reitz holds a patent for an "Implantable active substance depot material." This invention comprises a glass ionomer cement combined with one or more chemotherapeutic agents. The unique design of this active substance depot ensures an initially high release rate of the active substance, followed by a gradual discharge in small doses until the complete depletion of the deposited active substance occurs. This innovation has the potential to improve treatment outcomes in various medical applications.
Career Highlights
Reitz is associated with Thera Patent GmbH & Co. KG, where he continues to develop and refine his inventions. His work is characterized by a commitment to advancing medical technologies that can significantly impact patient care. With a focus on practical applications, he strives to bridge the gap between innovative ideas and real-world solutions.
Collaborations
Peter Reitz collaborates with notable professionals in his field, including Wolfgang Stille and Gabriele Gentschew. These partnerships enhance the development and implementation of his innovative ideas, fostering a collaborative environment that encourages creativity and progress.
Conclusion
Peter Reitz's contributions to the field of implantable active substance depot materials exemplify the importance of innovation in medical technology. His work not only showcases his expertise as an inventor but also highlights the potential for advancements that can improve patient outcomes.